Cargando…
Ranirestat Improves Electrophysiologic but not Clinical Measures of Diabetic Polyneuropathy: A Meta-Analysis
Ranirestat, an aldose reductase inhibitor evaluated in several randomised controlled trials (RCTs) in diabetic peripheral neuropathy (DPN). However, to date, no meta-analysis has evaluated the efficacy and safety of ranirestat in DPN. We undertook this meta-analysis to address this knowledge gap. De...
Autores principales: | Dutta, Deep, Mohindra, Ritin, Kumar, Manoj, Kumar, Ashok, Sharma, Meha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815196/ https://www.ncbi.nlm.nih.gov/pubmed/36618527 http://dx.doi.org/10.4103/ijem.ijem_242_22 |
Ejemplares similares
-
Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy
por: Bril, Vera, et al.
Publicado: (2009) -
Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023) -
Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy
por: Asano, Saeko, et al.
Publicado: (2019) -
Vitamin D, Thyroid Autoimmunity and Cancer: An Interplay of Different Factors
por: Dutta, Deep, et al.
Publicado: (2019) -
Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan
por: Sekiguchi, Kenji, et al.
Publicado: (2018)